Company intelligence / Profile preview

NalPharm

Nalchik, Kabardino-Balkarian Republic, Russia

Ownership: Private
Employees: ~150
Development stage: Other

Overview

Nalpharm is a Russian pharmaceutical company based in Nalchik, specializing in the production of sterile injectable antibiotics. The company operates a modern manufacturing facility that produces a range of cephalosporin antibiotics, including first, second, and third-generation variants. Nalpharm focuses on providing high-quality generic medications to the Russian healthcare market and neighboring regions. Its product portfolio includes widely used treatments such as Ceftriaxone, Cefotaxime, and Cefazolin. The company is recognized for its contribution to the regional pharmaceutical industry and its adherence to modern manufacturing standards.

Therapeutic areas: Infectious Diseases
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on NalPharm.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NalPharm.

Explore the full profile